See this entire activity.

Definition and Management of Suicidality in Psychiatric Patients

Jan A. Fawcett, MD (Chair); Ross J. Baldessarini, MD; William H. Coryell, MD; Morton M. Silverman, MD; and Dan J. Stein, MD, FRCPC

The US Food and Drug Administration warnings that psychotropic medications may increase the risk of suicidality have generated concern about prescribing these agents to patients with psychiatric disorders, many of whom are already at increased risk for suicide. To effectively prevent suicidal behaviors and suicide in clinical practice, clinicians must understand the dangers and benefits associated with psychotropic medications. In addition, they must learn how to identify and manage suicidal risk during treatment.

(J Clin Psychiatry 2009;70(10):e38. doi:10.4088/JCP.8145tx1c)

© Copyright 2009 Physicians Postgraduate Press, Inc.

From the University of New Mexico School of Medicine, Albuquerque (Dr Fawcett); Harvard Medical School and McLean Hospital, Belmont, Mass (Dr Baldessarini); Carver College of Medicine, University of Iowa, Iowa City (Dr Coryell); University of Chicago, Chicago, Ill (Dr Silverman); and University of Cape Town, Cape Town, South Africa, and Mt. Sinai School of Medicine, New York, NY (Dr Stein).